Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

Fätkenheuer, G; Duvivier, C; Rieger, A; Durant, J; Rey, D; Schmidt, W; Hill, A; van Delft, Y; Marks, S; J Antimicrob Chemother. 2012; 67(3): 685-690.

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).

Aapro, M; Molassiotis, A; Dicato, M; Peláez, I; Rodríguez-Lescure, Á; Pastorelli, D; Ma, L; Burke, T; Gu, A; Gascon, P; Roila, F; Ann Oncol. 2012; 23(8): 1986-1992.

An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.

Grünwald, V; Karakiewicz, PI; Bavbek, SE; Miller, K; Machiels, JP; Lee, SH; Larkin, J; Bono, P; Rha, SY; Castellano, D; Blank, CU; Knox, JJ; Hawkins, R; Anak, O; Rosamilia, M; Booth, J; Pirotta, N; Bodrogi, I; Eur J Cancer. 2012; 48(3): 324-332.

Treating T-cell lymphoma: is there a light at the end of the tunnel?_x000D_

Hopfinger, G; Merkel, O; Melchardt, T; Greil, R; Magazine of European Medical Oncology. 2012; 5 (3): 174-177.

A 55-year-old woman with locally advanced rectal cancer and a resectable synchronous hepatic metastasis: a case report.

Hohla, F; Mayer, P; Hutter, J; Meißnitzer, T; Greil, R; memo – Magazine of European Medical Oncology. 2012; 5 (4): 273-276.

The role of biomarkers in the choice of therapy in triple negative breast cancer

Mlineritsch, B; Ressler, S; Greil, R memo – Magazine of European Medical Oncology. 2012; 5: 101-104.

48-jähriger Patient mit fokal fortgeschrittenem, distalem Ösophaguskarzinom – Beispiel einer geglückten interdisziplinären Zusammenarbeit

Hohla, F; Vaszi, A; Datz, L; Rettenbacher, L; Hutter, J; Tumorboard. 2012; 1(1): 27-30.

[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

Pabinger, I; Gastl, G; Steurer, M; Sormann, S; Fillitz, M; Friedl, J; Geissler, D; Geissler, K; Greil, R; Knöbl, P; Kozek-Langenecker, S; Krippl, P; Kyrle, P; Lang, A; Linkesch, W; Ludwig, H; Müller, M; Panzer, S; Pittermann, E; Thaler, J; Weltermann, A; WIEN KLIN WOCHENSCHR. 2012; 124(3-4): 111-123.

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: updated results from a retrospective matched-pair analysis

Gampenrieder, SP; Romeder, F; Muss, C; Pircher, M; Ressler, S; Rinnerthaler, G; Bartsch, R; Sattlberger, C; Mlineritsch, B; Greil, R EUR J CANCER. 2013; 49: S417-S418.

Antiapoptotic effects of p21 regarding its subcellular localization in arsenic trioxide induced apoptosis in CLL

Sifft, E; Hofbauer, JP; Asslaber, D; Hartmann, TN; Merkel, O; Greil, R ONKOLOGIE. 2013; 36: 222-222.